联合检测肿瘤标志物在卵巢癌中的应用

卵巢肿瘤是女性生殖器常见的三大恶性肿瘤之一,严重威胁妇女健康,其发生、发展较为隐匿,由于卵巢癌早期无症状,缺乏有效的筛查手段,临床上80%的卵巢癌患者获得诊断时已是中晚期。因此早期确诊卵巢癌患者非常重要。应用多种血清肿瘤标志物联合检测有助于卵巢癌的早期发现,无疑也将提高卵巢癌患者的生存率,同时也有助于治疗中的病情监测、疗效评价及预后判断。

Application of Combined Measurement of Tumor Markers in Ovarian Cancer

Ovarian tumor is one of the three common malignant tumors in reproductive apparatus of females,which seriously threatens women′s health,as well as occurs and develops in negligence.Because there is no symptom in the early stage and lack of effective screening medium,80% of people who are diagnosed ovarian cancer is in mid-term and late period.Therefore,it′s very important for the sufferers to find out the ovarian cancer earlier.With the application of combined measurement of tumor markers,it can assist ovarian cancer diagnosis in the early stage and increase the rate of subsistence.At the same time,the combined measurement is good to the monitoring of the patients′condition,the evaluation of the curative effect and the determination of the prognosis.